Mehul Joshi - 06 May 2024 Form 4 Insider Report for Pulmonx Corp (LUNG)

Role: Chief Financial Officer & PAO
Signature: /s/ Lauren Cristina, Attorney-in-Fact
Issuer symbol: LUNG
Transactions as of: 06 May 2024
Net transactions value: $0
Form type: 4
Filing time: 07 May 2024, 17:44:34 UTC
Previous filing: 09 Apr 2024
Next filing: 05 Mar 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	LUNG	Common Stock	Award	$0	+125,870		$0.000000	125,870	06 May 2024	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	LUNG	Employee Stock Option (right to buy)	Award	$0	+241,409		$0.000000	241,409	06 May 2024	Common Stock	241,409	$9.28	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents grant of Restricted Stock Units award payable solely in common stock of the Issuer that vest in accordance with the following schedule: 25% vests on March 3, 2025, and the remainder of the award vests in equal quarterly installments over the subsequent three-year period.
F2	Twenty-five percent of the shares subject to the option vests on March 3, 2025, and the remainder vests in equal monthly installments over the subsequent three-year period.